253 related articles for article (PubMed ID: 22068472)
1. [Myositis-specific autoantibodies and their clinical significance].
Suzuki S
Brain Nerve; 2011 Nov; 63(11):1197-203. PubMed ID: 22068472
[TBL] [Abstract][Full Text] [Related]
2. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.
Gunawardena H; Betteridge ZE; McHugh NJ
Rheumatology (Oxford); 2009 Jun; 48(6):607-12. PubMed ID: 19439503
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
Mimori T; Imura Y; Nakashima R; Yoshifuji H
Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies and their clinical significance in idiopathic inflammatory myopathies; polymyositis/dermatomyositis and related conditions.
Hirakata M
Nihon Rinsho Meneki Gakkai Kaishi; 2007 Dec; 30(6):444-54. PubMed ID: 18174673
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies in polymyositis and dermatomyositis.
Ghirardello A; Bassi N; Palma L; Borella E; Domeneghetti M; Punzi L; Doria A
Curr Rheumatol Rep; 2013 Jun; 15(6):335. PubMed ID: 23591825
[TBL] [Abstract][Full Text] [Related]
6. The evolving spectrum of polymyositis and dermatomyositis--moving towards clinicoserological syndromes: a critical review.
Tansley S; Gunawardena H
Clin Rev Allergy Immunol; 2014 Dec; 47(3):264-73. PubMed ID: 24048686
[TBL] [Abstract][Full Text] [Related]
7. Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
Sarkar K; Weinberg CR; Oddis CV; Medsger TA; Plotz PH; Reveille JD; Arnett FC; Targoff IN; Genth E; Love LA; Miller FW
Arthritis Rheum; 2005 Aug; 52(8):2433-8. PubMed ID: 16052581
[TBL] [Abstract][Full Text] [Related]
8. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
[TBL] [Abstract][Full Text] [Related]
9. Association of distinct clinical subsets with myositis-specific autoantibodies towards anti-155/140-kDa polypeptides, anti-140-kDa polypeptides, and anti-aminoacyl tRNA synthetases in Japanese patients with dermatomyositis: a single-centre, cross-sectional study.
Fujikawa K; Kawakami A; Kaji K; Fujimoto M; Kawashiri S; Iwamoto N; Aramaki T; Ichinose K; Tamai M; Kamachi M; Nakamura H; Ida H; Origuchi T; Ishimoto H; Mukae H; Kuwana M; Kohno S; Takehara K; Sato S; Eguchi K
Scand J Rheumatol; 2009; 38(4):263-7. PubMed ID: 19444719
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease.
Hozumi H; Fujisawa T; Nakashima R; Johkoh T; Sumikawa H; Murakami A; Enomoto N; Inui N; Nakamura Y; Hosono Y; Imura Y; Mimori T; Suda T
Respir Med; 2016 Dec; 121():91-99. PubMed ID: 27888997
[TBL] [Abstract][Full Text] [Related]
11. Immune manifestations of inflammatory muscle disease.
Targoff IN
Rheum Dis Clin North Am; 1994 Nov; 20(4):857-80. PubMed ID: 7855326
[TBL] [Abstract][Full Text] [Related]
12. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
13. [Myositis-specific autoantibodies].
Fujimoto M
Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
[TBL] [Abstract][Full Text] [Related]
14. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
Mammen AL
Ann N Y Acad Sci; 2010 Jan; 1184():134-53. PubMed ID: 20146695
[TBL] [Abstract][Full Text] [Related]
15. [Recent advance in polymyositis and dermatomyositis research].
Kohsaka H
Nihon Rinsho; 2009 Mar; 67(3):523-8. PubMed ID: 19280927
[TBL] [Abstract][Full Text] [Related]
16. [Autoantibodies specifically detected in patients with polymyositis/dermatomyositis].
Sato S
Nihon Rinsho Meneki Gakkai Kaishi; 2006 Apr; 29(2):85-93. PubMed ID: 16651706
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy.
Satoh M; Tanaka S; Ceribelli A; Calise SJ; Chan EK
Clin Rev Allergy Immunol; 2017 Feb; 52(1):1-19. PubMed ID: 26424665
[TBL] [Abstract][Full Text] [Related]
18. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic inflammatory myopathy: autoantibody update.
Targoff IN
Curr Rheumatol Rep; 2002 Oct; 4(5):434-41. PubMed ID: 12217249
[TBL] [Abstract][Full Text] [Related]
20. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]